Détail de l'auteur
Auteur Philip O. Anderson |
Documents disponibles écrits par cet auteur (58)
Ajouter le résultat dans votre panier Faire une suggestion Affiner la recherche
Article : texte imprimé
Philip O. Anderson, Auteur ; Elizabeth V. Asztalos, Auteur ; La Leche League France, Auteur |Article : texte imprimé
Philip O. Anderson, Auteur ; La Leche League France, Traducteur |"La maladie de Raynaud touche 3-5 % de la population, sa prévalence étant environ 4 fois plus élevée chez les femmes que chez les hommes. Elle se caractérise par un vasospasme des vaisseaux sanguins au niveau des extrémités, et ce vasospasme peu[...]Article : texte imprimé
Article : texte imprimé
Philip O. Anderson, Auteur ; Palika Datta, Auteur ; Peter Gerrit Johannes ter Horst, Auteur |Article : texte imprimé
Article : texte imprimé
Domperidone is a drug that seems to evoke reactions from lactation professionals ranging from consternation to anger, and in the extreme, to conspiracy theories about backroom deals between regulators and infant formula companies. Although compl[...]Article : texte imprimé
Drugs are not the preferred method of weight loss, and information on them during breastfeeding is almost nonexistent. Several of them might cause adverse effects on the infant or on lactation itself. Nonabsorbable products such as orlistat and [...]Article : texte imprimé
Several genetic diseases have had advances in treatment, including some new drugs. This column will focus on a few of these drug therapies and their implications for breastfeeding. More detailed information and references on specific drugs can b[...]Article : texte imprimé
Raynaud's phenomenon (RP) occurs in 35% of the population, with the rate of occurrence in women about four times that in men. It is caused by vasospasm of the blood vessels in the extremities, including the nipple. RP of the nipple can be extre[...]Article : texte imprimé
Drug treatment of RA need not be a barrier to breastfeeding; however, careful drug selection is important. Low-dose methotrexate is a mainstay of therapy, and limited data have found no indication of toxicity in breastfed infants, but more data [...]Article : texte imprimé
The plethora of new drugs to treat hepatitis presents a confusing array of options to treat the nursing mother. LactMed has recently undertaken an extensive review of these drugs to put them into a consistent context. [extrait de l'article]Article : texte imprimé
Discussion of medication use during breastfeeding usually centers around potential harm to the nursing infant. However, another important consideration is that of drugs that interfere with lactation. These can be divided into two subcategories: [...]